Blog
RSS FeedPosted by Michael Wonder on 26 Nov 2016
Melinta Therapeutics submits Baxdela new drug application for hospital-treated skin infections
24 October 2016 - Melinta Therapeutics announced today that it has submitted new drug applications to the U.S. FDA for approval ...
Posted by Michael Wonder on 25 Nov 2016
A battle to change Medicare is brewing, whether Trump wants it or not
24 November 2016 - Donald J. Trump once declared that campaigning for “substantial” changes to Medicare would be a political ...
Posted by Michael Wonder on 24 Nov 2016
Trouble on the exchanges — does the United States owe billions to health insurers?
23 November 2016 - Yet another bruising fight has erupted over health care reform. ...
Posted by Michael Wonder on 24 Nov 2016
All-payer claims databases — uses and expanded prospects after Gobeille
23 November 2016 - Health care spending is approaching 20% of the U.S. gross domestic product, yet spending on research ...
Posted by Michael Wonder on 22 Nov 2016
Sanofi receives FDA approval of Soliqua 100/33, for the treatment of adults with type 2 diabetes
21 November 2016 - Sanofi announced today that the U.S. FDA approved once-daily Soliqua 100/33 (insulin glargine & lixisenatide injection) ...
Posted by Michael Wonder on 22 Nov 2016
High prices for some leukaemia drugs will make them less cost-effective
21 November 2016 - Pills used to treat a form of leukaemia may be more effective and convenient than chemotherapy, ...
Posted by Michael Wonder on 22 Nov 2016
Mallinckrodt will initiate company-sponsored clinical trial of H.P. Acthar Gel in treatment of amyotropic lateral sclerosis
21 November 2016 - Investigational new drug application for use of H.P Acthar Gel in amyotropic lateral sclerosis awarded fast ...
Posted by Michael Wonder on 22 Nov 2016
U.S. FDA grants fast track designation for the development of Oragenics’ AG013 for oral mucositis
21 November 2016 - Oragenics today announced that the U.S. FDA granted fast track designation to AG013, the Company’s lead ...
Posted by Michael Wonder on 22 Nov 2016
Novo Nordisk receives US FDA approval for Xultophy 100/3.6
21 November 2016 - Novo Nordisk today announced that the US FDA has approved the new drug application for Xultophy 100/3.6. ...
Posted by Michael Wonder on 22 Nov 2016
Genmab announces U.S. FDA approval of Darzalex (daratumumab) for relapsed multiple myeloma
21 November 2016 - Darzalex (daratumumab) approved by U.S. FDA in combination with lenalidomide and dexamethasone, or bortezomib and dexamethasone for ...
Posted by Michael Wonder on 21 Nov 2016
Regeneron CEO: A few ‘bad actors’ are raising drug prices for no reason
19 November 2016 - At an EY forum on Friday, the CEO of Regeneron Pharmaceuticals acknowledged that “really bad actors” ...
Posted by Michael Wonder on 21 Nov 2016
Pfizer sues Texas health agency for releasing confidential pricing information
18 November 2016 - Pfizer has sued Texas' health agency, claiming it violated state and federal law by releasing the ...
Posted by Michael Wonder on 21 Nov 2016
GSK files regulatory submission in US for once-daily closed triple combination therapy FF/UMEC/VI for patients with COPD
21 November 2016 - GSK and Innoviva today announced the filing by GSK of a regulatory submission with the US ...
Posted by Michael Wonder on 21 Nov 2016
Many insured children lack essential health care, study finds
20 November 2016 - Margo Solomon has health insurance for herself and her four children. ...
Posted by Michael Wonder on 21 Nov 2016
The future of health care mergers under Trump
20 November 2016 - The proposed health insurance mega-merger between Anthem and Cigna heads to court on Monday, as the ...